Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRMD | SLN |
|---|---|---|
| Price | $7.28 | $9.82 |
| Change today | ▲ 0.00% | ▼ 0.10% |
| Market cap | $567.43M | $610.35M |
| Return, 3 months | -16.0% | -0.4% |
| Return, year to date | -37.4% | +61.5% |
| Return, 1 year | -35.4% | +87.0% |
| P/E (TTM) | 3.3 | -7.6 |
| P/B | 1.2 | 15.9 |
| P/E percentile vs own 5y | 75th | 41st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +149.9% | -100.0% |
| Net profit growth (YoY) | +31.1% | +55.2% |
| Gross margin | 82.6% | 85.9% |
| Operating margin | 47.5% | -11,106.8% |
| Net margin | 40.7% | -9,748.5% |
| Return on equity | 54.6% | -90.4% |
| Analyst target vs. price | +92.3% | +276.8% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 35 | 24 |
| 30-day volatility | 24.3% | 45.1% |
| Max drawdown, 1 year | -50.9% | -41.9% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
